Jean-Charles Soria’s discussion about Annals Of Oncology’s evolution and its impact on oncology – ESMO
ESMO – European Society for Medical Oncology shared a post on LinkedIn:
“To mark the 35th anniversary of Annals Of Oncology, Prof. Jean-Charles Soria, Editor-in-Chief from 2014 to 2017, discusses the journal’s evolution and its impact on oncology. He reflects on key milestones, including the rise of immuno-oncology and the journal’s success in improving its impact factor.
Read the full interview.”
More posts featuring ESMO.
The European Society for Medical Oncology (ESMO) represents over 35,000 oncology professionals across 172 countries and is a key resource for oncology education and information. ESMO’s primary mission is to enhance the quality of cancer care, spanning prevention, diagnosis, palliative care, and patient follow-up.
It focuses on educating doctors, cancer patients, and the general public about best practices and the latest advancements in oncology, and advocates for equal access to optimal cancer care for all patients.
Jean-Charles Soria serves as Amgen’s senior vice president of Oncology within Global Development. He is a medical oncologist and a professor of medicine at Paris-Saclay University. From 2017 to 2019, he was the senior vice president of Research and Development in Oncology at AstraZeneca.
Additionally, Soria has authored or co-authored over 670 articles in leading international journals and has been recognized as one of the world’s most influential research scientists.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023